Patents by Inventor Fereydoun G. Sajjadi

Fereydoun G. Sajjadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5968784
    Abstract: The present invention provides novel methods for identifying gene expression patterns in mRNA populations. The methods are useful for determining differential gene expression among various cells or tissues, including cells or tissues of a target organism. The invention also provides methods of determining the frequency of gene expression in mRNA populations, thus providing a method of comparing gene expression frequency among various cells or tissues. The present invention also provides methods for isolating genes corresponding to tag sequences identified according to the methods of the present invention. Furthermore, sequences that are identified according to the present invention may be used to diagnose the presence of disease.
    Type: Grant
    Filed: January 15, 1997
    Date of Patent: October 19, 1999
    Assignee: Chugai Pharmaceutical Co., Ltd.
    Inventors: Dominic G. Spinella, Fereydoun G. Sajjadi
  • Patent number: 5457048
    Abstract: The invention is directed to substantially purified Eph-related protein tyrosine kinases, or functional fragments thereof, having about 23 to 66 percent amino acid sequence identity in their carboxyl terminal variable regions compared to known members of the Eph subclass of tyrosine kinases. Nucleic acids encoding such Eph-related protein tyrosine kinases, vectors and host cells are also provided. The invention is also directed to a method of diagnosing cancer and determining cancer prognosis. The method includes removing a tissue or cell sample from a subject suspected of having cancer and determining the level of Eph-related protein tyrosine kinase in the sample, wherein a change in the level or activity of a Eph-related protein tyrosine kinase compared to a normal sample indicates the presence of a cancer or indicates the level of malignancy of a cancer.
    Type: Grant
    Filed: December 3, 1993
    Date of Patent: October 10, 1995
    Assignee: La Jolla Cancer Research Foundation
    Inventors: Elena B. Pasquale, Fereydoun G. Sajjadi